What is Novonesis (Novozymes) B Price-to-Operating-Cash-Flow?
As of today (2025-06-04), Novonesis (Novozymes) B's share price is kr461.95.
Novonesis (Novozymes) B's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr15.02. Hence, Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow Ratio for today is 30.77.
The historical rank and industry rank for Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow or its related term are showing as below:
CHIX:NSISBc'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 16.87 Med: 26.17 Max: 35.76
Current: 30.66
During the past 13 years, Novonesis (Novozymes) B's highest Price-to-Operating-Cash-Flow Ratio was 35.76. The lowest was 16.87. And the median was 26.17.
Novonesis (Novozymes) B's Cash Flow from Operations per share for the
three
months ended in Mar. 2025 was kr1.70.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr15.02.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Novonesis (Novozymes) B was -12.60% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.50% per year.
During the past 13 years, Novonesis (Novozymes) B's highest 3-Year average Operating Cash Flow per Share Growth Rate was 19.20% per year. The lowest was -4.20% per year. And the median was 6.80% per year.
Novonesis (Novozymes) B Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novonesis (Novozymes) B Price-to-Operating-Cash-Flow Chart
|
Novonesis (Novozymes) B Annual Data
|
|
Trend |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
22.64 |
37.07 |
24.52 |
24.83 |
24.64 |
|
Novonesis (Novozymes) B Quarterly Data
|
|
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Dec24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
24.83 |
17.98 |
17.93 |
24.64 |
26.71 |
Competitive Comparison of Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow
For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow falls into.
Novonesis (Novozymes) B Price-to-Operating-Cash-Flow Calculation
Novonesis (Novozymes) B's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 461.95 | / | 15.015 |
| = | 30.77 |
Novonesis (Novozymes) B's Share Price of today is kr461.95.
Novonesis (Novozymes) B's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr15.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Novonesis (Novozymes) B Business Description
Traded in Other Exchanges
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
Novonesis (Novozymes) B Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHIX:NSISBC has been successfully added to your